T. Rowe Price Investment Management
MDLN

T. Rowe Price Investment Management’s Medline Inc MDLN Stock Holding History

T. Rowe Price Investment Management’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-7,106,211
Closed -$298M – 968
2025
Q4 		$298M Buy
+7,106,211
New +$300M 0.19% 129

Other funds holding MDLN

CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

T. Rowe Price Investment Management's MDLN Position: Q1 2026 in Review

T. Rowe Price Investment Management sold out of Medline Inc (MDLN) in Q1 2026, closing a stake of 7,106,211 shares — an estimated $298M sold.

T. Rowe Price Investment Management first reported a position in MDLN in Q4 2025 and held it in 1 quarter. The position peaked at $298M in Q4 2025. 314 funds tracked by Wall St. Rank hold MDLN as of Q1 2026.

  • T. Rowe Price Investment Management reported no remaining Medline Inc position as of Q1 2026 after selling out during the quarter.
  • T. Rowe Price Investment Management sold 7,106,211 Medline Inc shares in Q1 2026, an estimated $298M.
  • T. Rowe Price Investment Management first reported a position in Medline Inc in Q4 2025 and held it in 1 quarter.
  • T. Rowe Price Investment Management's Medline Inc position peaked at $298M in Q4 2025.
  • 314 funds tracked by Wall St. Rank held Medline Inc as of Q1 2026.

Based on T. Rowe Price Investment Management's 13F filing for Q1 2026, filed 15 May 2026.